Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 40001-40050 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05859750
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
PHASE2
Recruiting
78 participants
Started: May 25, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT05317832
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
PHASE2
Recruiting
196 participants
Started: May 25, 2023 · Completed: Sep 30, 2026
1 condition
8 sponsors
1 location
NCT05828147
Anti-CD20 Antibodies for Treatment of SLE-PAH
PHASE4
Recruiting
50 participants
Started: May 25, 2023 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT06150144
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
PHASE3
Recruiting
40 participants
Started: May 25, 2023 · Completed: May 25, 2025
2 conditions
2 sponsors
1 location
NCT05433116
Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC
PHASE2
Recruiting
50 participants
Started: May 25, 2023 · Completed: Sep 30, 2026
1 condition
1 sponsor
10 locations
NCT07215754
Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients
N/A
Recruiting
300 participants
Started: May 25, 2023 · Completed: May 31, 2031
1 condition
1 sponsor
1 location
NCT05851326
Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome
NA
Recruiting
126 participants
Started: May 25, 2023 · Completed: Oct 31, 2025
3 conditions
7 sponsors
6 locations
NCT05871853
Get the Benefits From the Start. Improving Breastfeeding
N/A
Recruiting
1,600 participants
Started: May 25, 2023 · Completed: Dec 31, 2028
1 condition
4 sponsors
1 location
NCT06341660
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)
PHASE2
Recruiting
30 participants
Started: May 25, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05687526
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus
PHASE1
Recruiting
12 participants
Started: May 25, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
12 locations
NCT05939661
A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer
PHASE2
Recruiting
45 participants
Started: May 25, 2023 · Completed: Mar 31, 2030
1 condition
1 sponsor
2 locations
NCT05679284
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
N/A
Recruiting
100 participants
Started: May 25, 2023 · Completed: Nov 15, 2028
5 conditions
3 sponsors
1 location
NCT05829421
Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments
NA
Recruiting
7 participants
Started: May 25, 2023 · Completed: Dec 2, 2025
2 conditions
5 sponsors
4 locations
NCT06346106
The Diagnostic Experience of Male Rett Syndrome
N/A
Recruiting
80 participants
Started: May 24, 2023 · Completed: Apr 30, 2024
2 conditions
7 sponsors
1 location
NCT06143423
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
PHASE1
Recruiting
74 participants
Started: May 24, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05122767
Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)
PHASE1/PHASE2
Recruiting
92 participants
Started: May 24, 2023 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT05673304
Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer
NA
Recruiting
30 participants
Started: May 24, 2023 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT04119908
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NA
Recruiting
400 participants
Started: May 24, 2023 · Completed: May 24, 2028
2 conditions
1 sponsor
1 location
NCT05865028
A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
PHASE2
Recruiting
32 participants
Started: May 24, 2023 · Completed: May 24, 2028
3 conditions
2 sponsors
1 location
NCT05473520
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
PHASE3
Recruiting
150 participants
Started: May 24, 2023 · Completed: Jan 31, 2030
3 conditions
7 sponsors
6 locations
NCT05810870
PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin
PHASE2
Recruiting
14 participants
Started: May 24, 2023 · Completed: Jul 31, 2027
3 conditions
2 sponsors
13 locations
NCT05398484
Psilocybin Therapy in Advanced Cancer
PHASE2/PHASE3
Recruiting
300 participants
Started: May 24, 2023 · Completed: Jan 1, 2027
1 condition
2 sponsors
2 locations
NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
PHASE4
Recruiting
100 participants
Started: May 24, 2023 · Completed: Nov 30, 2026
2 conditions
1 sponsor
9 locations
NCT05942287
The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.
NA
Recruiting
110 participants
Started: May 24, 2023 · Completed: Dec 31, 2026
4 conditions
2 sponsors
2 locations
NCT05870020
Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation
NA
Recruiting
146 participants
Started: May 24, 2023 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT05713695
Supporting Treatment Access and Recovery Through Linkage and Support
NA
Recruiting
208 participants
Started: May 24, 2023 · Completed: Sep 30, 2026
2 conditions
4 sponsors
1 location
NCT06894095
Dongzong Cardiovascular Bio-imaging Registry Study
N/A
Recruiting
50,000 participants
Started: May 24, 2023 · Completed: May 31, 2038
4 conditions
1 sponsor
1 location
NCT06256718
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
NA
Recruiting
560 participants
Started: May 24, 2023 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
NCT05555485
Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
NA
Recruiting
60 participants
Started: May 24, 2023 · Completed: Sep 30, 2027
2 conditions
3 sponsors
1 location
NCT05215587
Scandinavian Trial of Uncomplicated Aortic Dissection Therapy
NA
Recruiting
554 participants
Started: May 24, 2023 · Completed: Dec 31, 2030
1 condition
3 sponsors
28 locations
NCT05080556
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
PHASE2
Recruiting
80 participants
Started: May 24, 2023 · Completed: Nov 1, 2027
7 conditions
4 sponsors
1 location
NCT05404139
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
PHASE2
Recruiting
132 participants
Started: May 24, 2023 · Completed: Mar 31, 2026
1 condition
2 sponsors
2 locations
NCT06593145
CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms
PHASE1
Recruiting
6 participants
Started: May 24, 2023 · Completed: Jun 30, 2025
3 conditions
1 sponsor
2 locations
NCT05856318
Cardiometabolic Health in First Time Pregnancy
N/A
Recruiting
3,500 participants
Started: May 24, 2023 · Completed: Dec 31, 2052
5 conditions
9 sponsors
7 locations
NCT05861245
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NA
Recruiting
20 participants
Started: May 24, 2023 · Completed: May 24, 2033
2 conditions
1 sponsor
1 location
NCT03826524
Epinephrine Dose: Optimal Versus Standard Evaluation Trial
PHASE4
Recruiting
3,790 participants
Started: May 24, 2023 · Completed: Jun 30, 2028
4 conditions
3 sponsors
3 locations
NCT06148298
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
N/A
Recruiting
24 participants
Started: May 24, 2023 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05390853
Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients
NA
Recruiting
30 participants
Started: May 24, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05600686
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
PHASE2
Recruiting
24 participants
Started: May 24, 2023 · Completed: Feb 1, 2028
4 conditions
3 sponsors
1 location
NCT06227780
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
NA
Recruiting
180 participants
Started: May 24, 2023 · Completed: May 24, 2028
4 conditions
2 sponsors
1 location
NCT05840198
LH Canine Therapy Study
NA
Recruiting
48 participants
Started: May 24, 2023 · Completed: Dec 31, 2025
3 conditions
2 sponsors
2 locations
NCT05888597
Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease
PHASE2
Recruiting
20 participants
Started: May 24, 2023 · Completed: Dec 30, 2024
1 condition
2 sponsors
1 location
NCT05722340
NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases
NA
Recruiting
24 participants
Started: May 24, 2023 · Completed: Nov 24, 2026
1 condition
2 sponsors
1 location
NCT05721404
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
PHASE4
Recruiting
194 participants
Started: May 24, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06697535
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
PHASE2
Recruiting
35 participants
Started: May 24, 2023 · Completed: Jul 30, 2026
1 condition
1 sponsor
1 location
NCT05907980
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
PHASE1
Recruiting
219 participants
Started: May 24, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
4 locations
NCT05559736
Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures
NA
Recruiting
20 participants
Started: May 24, 2023 · Completed: Jun 30, 2026
3 conditions
2 sponsors
1 location
NCT05895383
Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy
PHASE4
Recruiting
35 participants
Started: May 24, 2023 · Completed: Jan 30, 2025
3 conditions
1 sponsor
1 location
NCT04086082
Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
NA
Recruiting
30 participants
Started: May 24, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05890183
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NA
Recruiting
100 participants
Started: May 23, 2023 · Completed: May 31, 2028
3 conditions
2 sponsors
1 location
Previous
1
More pages
798
799
800
801
802
803
804
More pages
1333
Next